Merck & Company Inc. is a prominent global pharmaceutical leader headquartered in Kenilworth, New Jersey, committed to driving advancements in healthcare through innovative drug development and vaccines. Established in 1891, Merck has built a robust portfolio focused on key therapeutic areas, including oncology, infectious diseases, and cardiovascular health, supported by a strong clinical pipeline and substantial investments in research and development. The company's strategic partnerships and dedication to improving patient outcomes underscore its role in the evolving biopharmaceutical industry, positioning Merck for continued growth and impact in global health initiatives.

NYSE

USA

HEALTHCARE

DRUG MANUFACTURERS - GENERAL

126 EAST LINCOLN AVENUE, RAHWAY, NJ, UNITED STATES, 07065

December

$277 Billion

$31.5 Billion

14.68

7.56

$3.20

2.95%

0.298